Stay updated on ADXS-503 & Pembro in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the ADXS-503 & Pembro in Lung Cancer Clinical Trial page.

Latest updates to the ADXS-503 & Pembro in Lung Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded a consolidated 'Locations' section listing participating sites by state (CA, GA, IL, KS, NJ, NY, OR, VA). Removed the old per-state 'Locations' headers and the 'HHS Vulnerability Disclosure' link.SummaryDifference0.9%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedFooter revision log updated: added Revision v3.3.2 and removed Revision v3.2.0; no substantive changes to study details, eligibility, contacts, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check48 days agoChange DetectedThe funding-status notice at the top of the page has been removed, and the study details, locations, eligibility criteria, and results information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check63 days agoChange DetectedResults for the study have been posted, and the Study Record Dates now reflect when the results were submitted and posted.SummaryDifference0.4%

- Check91 days agoChange Detected- Added a government funding lapse notice and operating-status guidance, and confirmed the NIH Clinical Center is open with sources. - Version updated from v3.1.0 to v3.2.0.SummaryDifference2%

- Check98 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes are evident.SummaryDifference0.1%

Stay in the know with updates to ADXS-503 & Pembro in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADXS-503 & Pembro in Lung Cancer Clinical Trial page.